Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

GalNAc4ST-1 Activators

GalNAc4ST-1 Activators are a class of compounds that influence the glycosylation process by modulating the activity of enzymes involved in the addition of sugar moieties to proteins and lipids. The activity of GalNAc4ST-1, a specific sulfotransferase, can be enhanced indirectly by compounds that affect the overall glycosylation landscape within the cell. For instance, EGF can activate the EGFR pathway, which is known to enhance glycosylation processes, thereby increasing the functional demand for GalNAc4ST-1. Forskolin, by increasing cAMP, can enhance the activity of various glycosyltransferases, including GalNAc4ST-1, by amplifying the cellular conditions necessary for effective glycosylation and sulfation of glycoproteins.

Moreover, compounds such as PMA and Ionomycin modify intracellular signaling through PKC activation and calcium influx, respectively, which are critical regulators of enzyme activity in the glycosylation pathway. This regulation can lead to an increase in the phosphorylation state of proteins and enzymes, including GalNAc4ST-1, enhancing their activity. Additionally, the availability of specific substrates and inhibitors such as UDP-GalNAcand Benzyl-α-GalNAc plays a pivotal role in dictating the activity of glycosylation enzymes. UDP-GalNAc directly provides the necessary sugar substrate that GalNAc4ST-1 transfers, and the modulation of its availability can control the enzymatic activity of GalNAc4ST-1. In contrast, Benzyl-α-GalNAc can inhibit competing glycosyltransferases, freeing up more substrate for GalNAc4ST-1 to act upon, thereby enhancing its function.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

By elevating cAMP levels, Forskolin can increase the activity of glycosyltransferases, indirectly enhancing the sulfation of glycoconjugates by GalNAc4ST-1.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates PKC, which may enhance the phosphorylation state of proteins involved in glycosylation, potentially upregulating GalNAc4ST-1 activity.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin increases intracellular calcium levels, which can activate enzymes in the glycosylation pathway, possibly leading to enhanced GalNAc4ST-1 function.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Although primarily an inhibitor of N-linked glycosylation, Tunicamycin's stress on the ER can lead to compensatory mechanisms that enhance O-linked glycosylation, potentially involving GalNAc4ST-1.

D-Mannose

3458-28-4sc-211180
sc-211180A
100 g
250 g
$103.00
$161.00
1
(1)

Mannosamine is involved in sialic acid metabolism and could increase the substrate availability for O-linked glycosylation, indirectly enhancing GalNAc4ST-1 activity.

UDP-N-acetyl-D-galactosamine disodium salt

108320-87-2sc-286850
sc-286850A
sc-286850B
sc-286850C
1 mg
2 mg
25 mg
100 mg
$124.00
$292.00
$1326.00
$3876.00
(0)

As the direct donor substrate for GalNAc4ST-1, increased availability of UDP-GalNAc can enhance the protein's sulfotransferase activity.

Benzyl-2-acetamido-2-deoxy-α-D-galactopyranoside

3554-93-6sc-203427
sc-203427A
100 mg
1 g
$350.00
$3184.00
2
(0)

This molecule acts as a competitive inhibitor for other glycosyltransferases, which could indirectly increase the substrate availability for GalNAc4ST-1.